Pfizer has entered into a business transfer agreement to sell its Thane plant to Vidhi Research and Development for ₹1.78 billion (US$27.4 million). The plant was commissioned in the 1960s and supplied drugs to both domestic and international markets.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.